The goal of the James lab is to learn how human B cells differentiate into long-lived antibody-secreting plasma cells. We would like to better understand how dysregulated B cell differentiation can contribute to plasma cell-associated immune diseases, including primary immune deficiency, rheumatoid arthritis and lupus. We leverage what we learn to develop B cell-based therapies.
Richard G. James, PhD
For questions or inquiries,
Center for Immunity and Immunotherapies
1900 Ninth Ave.
Seattle, WA 98101